Abstract
It has been shown that injection of lipopolysaccharides, derived from a variety of Gram-negative bacterial species, evokes in mice a rapidly developing rise in resistance to infection with Gram-negative pathogens. This is accompanied by an elevation in properdin titer, at times to levels 2 to 3 times the normal. The rate, magnitude, and duration of these responses are dependent on many factors, the most important of which are the quantity and timing of the lipopolysaccharide administered. The increased resistance to infection evoked in mice by lipopolysaccharides was effective against infections produced by endotoxin-bearing organisms-bacterial species highly susceptible in vitro to the bactericidal action of the properdin system. Properdin titers of mice prior to infection provide an incomplete picture of the subsequent reaction of the host to the infective agent. Following infection with Gram-negative organisms, properdin levels accurately reflect the bacteriologic course and outcome of the infection. Thus, in control animals, properdin titers progressively declined and the animals died, while in mice appropriately treated with lipopolysaccharide, properdin levels were either maintained in the normal range or increased, depending on the dose and time of administration of lipopolysaccharide; this was always accompanied by successful management of the infection. The complex nature of the alterations produced in the host by lipopolysaccharides is stressed. It is pointed out that the increase in the ability of the host to cope with Gram-negative infections may be the result of stimulation of other defense mechanisms, in addition to the properdin system.
Full Text
The Full Text of this article is available as a PDF (1.4 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CREECH H. J., HANKWITZ R. F., Jr, WHARTON D. R. A. Further studies of the immunological properties of polysaccharides from Serratia marcescens (Bacillus prodigiosus) the effects of passive and active immunization on the lethal activity of the polysaccharides. Cancer Res. 1949 Mar;9(3):150–157. [PubMed] [Google Scholar]
- DAVIES D. A., MORGAN W. T., RECORD B. R. Studies in immunochemistry. 15. The specific polysaccharide of the dominant 'O' somatic antigen of Shigella dysenteriae. Biochem J. 1955 Jun;60(2):290–303. doi: 10.1042/bj0600290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DIGEON M., RAYNAUD M., TURPIN A. Etude de la toxine R2 du bacille typhique (Eberthella typhosa). Ann Inst Pasteur (Paris) 1952 Feb;82(2):206–220. [PubMed] [Google Scholar]
- FIELD T. E., HOWARD J. G., WHITBY J. L. Studies on the rapid production of a non-specific type of immunity to Salmonella typhi infection in mice. J R Army Med Corps. 1955 Oct;101(4):324–334. [PubMed] [Google Scholar]
- FRANK E., FINE J., PILLEMER L. Serum properdin levels in hemorrhagic shock. Proc Soc Exp Biol Med. 1955 Jun;89(2):223–225. doi: 10.3181/00379727-89-21764. [DOI] [PubMed] [Google Scholar]
- LAMBERT H. P., RICHLEY J. The action of mucin in promoting infections: the anticomplementary effect of mucin extracts and certain other substances. Br J Exp Pathol. 1952 Aug;33(4):327–339. [PMC free article] [PubMed] [Google Scholar]
- LANDY M., PILLEMER L. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides. J Exp Med. 1956 Jun 1;103(6):823–833. doi: 10.1084/jem.103.6.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LANDY M., WEBSTER M. E. Studies on Vi antigen. III. Immunological properties of purified Vi antigen derived from Escherichia coli 5396/38. J Immunol. 1952 Aug;69(2):143–154. [PubMed] [Google Scholar]
- NESSET N. M., McLALLEN J., ANTHONY P. Z., GINGER L. G. Bacterial pyrogens. I. Pyrogenic preparation from a Pseudomonas species. J Am Pharm Assoc Am Pharm Assoc. 1950 Aug;39(8):456–459. doi: 10.1002/jps.3030390810. [DOI] [PubMed] [Google Scholar]
- PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
- PILLEMER L., BLUM L., LEPOW I. H., WURZ L., TODD E. W. The properdin system and immunity. III. The zymosan assay of properdin. J Exp Med. 1956 Jan 1;103(1):1–13. doi: 10.1084/jem.103.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PILLEMER L., SCHOENBERG M. D., BLUM L., WURZ L. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science. 1955 Sep 23;122(3169):545–549. doi: 10.1126/science.122.3169.545. [DOI] [PubMed] [Google Scholar]
- PILLEMER L. The properdin system. Trans N Y Acad Sci. 1955 May;17(7):526–530. [PubMed] [Google Scholar]
- ROWLEY D. Stimulation of natural immunity to Escherichia coli infection: observations on mice. Lancet. 1955 Jan 29;268(6857):232–234. doi: 10.1016/s0140-6736(55)90163-x. [DOI] [PubMed] [Google Scholar]
- THOMAS L. The physiological disturbances produced by endotoxins. Annu Rev Physiol. 1954;16:467–490. doi: 10.1146/annurev.ph.16.030154.002343. [DOI] [PubMed] [Google Scholar]
- WARDLAW A. C., PILLEMER L. The properdin system and immunity. V. The bactericidal activity of the properdin system. J Exp Med. 1956 May 1;103(5):553–575. doi: 10.1084/jem.103.5.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WEBSTER M. E., SAGIN J. F., LANDY M., JOHNSON A. G. Studies on the O antigen of Salmonella typhosa. I. Purification of the antigen. J Immunol. 1955 Jun;74(6):455–465. [PubMed] [Google Scholar]
- WHARTON D. R. A., CREECH H. J. Further studies of the immunological properties of polysaccharides from Serratia marcescens (Bacillus prodigiosus) nature of the antigenic action and the antibody response in mice. J Immunol. 1949 Jun;62(2):135–153. [PubMed] [Google Scholar]